Education
About Us
Working with TipRanks
Follow Us
Pro Medicus Limited (AU:PME)
ASX:PME
Total Valuation
Pro Medicus Limited has a market cap or net worth of $26.17B. The enterprise value is AU$29.63B.
Market Cap$26.17B
Enterprise ValueAU$29.63B
Share Statistics
Pro Medicus Limited has 104,510,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding104,510,840
Owned by Insiders46.26%
Owned by Institutions0.08%
Financial Efficiency
Pro Medicus Limited’s return on equity (ROE) is 0.45 and return on invested capital (ROIC) is 37.45%.
Return on Equity (ROE)0.45
Return on Assets (ROA)0.34
Return on Invested Capital (ROIC)37.45%
Return on Capital Employed (ROCE)0.53
Revenue Per Employee2.69M
Profits Per Employee0.00
Employee Count79
Asset Turnover0.63
Inventory Turnover3.15
Valuation Ratios
The current PE Ratio of Pro Medicus Limited is 227.7. Pro Medicus Limited’s PEG ratio is 6.59.
PE Ratio227.7
PS Ratio139.89
PB Ratio115.91
Price to Fair Value115.91
Price to FCF286.51
Price to Operating Cash Flow226.07
PEG Ratio6.59
Income Statement
In the last 12 months, Pro Medicus Limited had revenue of 212.91M and earned 115.22M in profits. Earnings per share was 1.10.
Revenue212.91M
Gross Profit212.60M
Operating Income157.61M
Pretax Income163.31M
Net Income115.22M
EBITDA164.85M
Earnings Per Share (EPS)1.10
Cash Flow
In the last 12 months, operating cash flow was 118.87M and capital expenditures -439.00K, giving a free cash flow of 118.43M billion.
Operating Cash Flow118.87M
Free Cash Flow118.43M
Free Cash Flow per Share1.13
Dividends & Yields
Pro Medicus Limited pays an annual dividend of AU$0.3, resulting in a dividend yield of 0.22%
Dividend Per ShareAU$0.3
Dividend Yield0.22%
Payout Ratio98.93%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.65
52-Week Price Change16.88%
50-Day Moving Average284.91
200-Day Moving Average275.22
Relative Strength Index (RSI)34.16
Average Volume (3m)152.66K
Important Dates
Pro Medicus Limited upcoming earnings date is Feb 17, 2026, TBA (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateFeb 17, 2026
Ex-Dividend DateSep 03, 2025
Financial Position
Pro Medicus Limited as a current ratio of 6.49, with Debt / Equity ratio of 0.88%
Current Ratio6.49
Quick Ratio6.49
Debt to Market Cap<0.01
Net Debt to EBITDA-1.05
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pro Medicus Limited has paid 48.09M in taxes.
Income Tax48.09M
Effective Tax Rate0.29
Enterprise Valuation
Pro Medicus Limited EV to EBITDA ratio is 179.63, with an EV/FCF ratio of 284.85.
EV to Sales139.08
EV to EBITDA179.63
EV to Free Cash Flow284.85
EV to Operating Cash Flow265.98
Balance Sheet
Pro Medicus Limited has $209.19M in cash and marketable securities with $2.25M in debt, giving a net cash position of $206.93M billion.
Cash & Marketable Securities$209.19M
Total Debt$2.25M
Net Cash$206.93M
Net Cash Per Share$1.98
Tangible Book Value Per Share$2.26
Margins
Gross margin is 79.42%, with operating margin of 74.03%, and net profit margin of 54.12%.
Gross Margin79.42%
Operating Margin74.03%
Pretax Margin76.71%
Net Profit Margin54.12%
EBITDA Margin77.43%
EBIT Margin74.03%
Analyst Forecast
The average price target for Pro Medicus Limited is $328.96, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$328.96
Price Target Upside31.39% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast31.88%
EPS Growth Forecast39.10%